没听昨天总统直播,昨天就涨了300%,总统提振股市是一把好手。
浏览附件916681
Kodak Stock Is Up 300% Today. It Has Nothing to Do With Photography.
The company that invented the digital camera is staging a comeback that has nothing to do with photography.
That’s right,
Kodak is still a thing. Its stock was up more than 300% in trading Tuesday after
The Wall Street Journal reported the iconic photography company will receive a $765 million loan from the U.S. government to produce medical ingredients, including hydroxychloroquine. It’s the first loan of its kind under the Defense Production Act and is part of an American push to bring production back to the U.S., ending reliance on foreign sourcing.
But should the stock be up triple-digits? It’s hard to say. No one was paying attention to the company on Wall Street. There are no analysts covering the microcap stock.
Kodak filed for bankruptcy protection in 2012 and emerged as a new corporate entity around the end of 2013. These days, the company is focused on imaging and producing chemicals, consumable products, and software for the industry. As of Monday’s closing prices, Kodak’s market value, including debt and preferred stock, was less than $300 million. That’s why a $765 million loan from the government is a really big deal.
Kodak Stock Is Up 300% Today. It Has Nothing to Do With Photography.
What’s in the Republican coronavirus relief package, Moderna and Pfizer begin Phase 3 vaccine trials, two Major League Baseball games are called off after infections, and other news to start your day.
www.barrons.com
Kodak tapped to be leader in U.S. prescription drug manufacturing
Kodak tapped to be leader in U.S. prescription drug manufacturing
Eastman Kodak Company is poised to be on the forefront of a federal initiative to shift production of generic prescription drugs to the U. S. , including some used in the fight against COVID-19. A $765 million federal loan through the U. S. International Development Finance Corporation (DFC)...
13wham.com